BackTaiwan Biomaterial , Ltd. Overview

Taiwan Biomaterial , Ltd. Receivables

Taiwan Biomaterial , Ltd.'s receivables is $47M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$47.29M
↑ 43.48% YoYΔ $14.33M vs prior year quarter

Peer trimmed avg / median

Loading

Taiwan Biomaterial , Ltd. Receivables History

Loading

Taiwan Biomaterial , Ltd. vs. peers: Receivables Comparison

Loading

Taiwan Biomaterial , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Taiwan Biomaterial , Ltd. (6649.TWO) FAQ

As of the most recent data (September 2026), 6649.TWO shows a receivables of $47M. That compares with $33M in the prior-year period — up 43.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6649.TWO's receivables is now $47M (was $33M) — a 43.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Taiwan Biomaterial , Ltd. is outperforming or lagging.

Tracking 6649.TWO's receivables over time shows whether Taiwan Biomaterial , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $47M That compares with $33M in the prior-year period — up 43.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Taiwan Biomaterial , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $47M) with ownership activity and broader fundamentals.